In the limited analyses of gout subjects to date in genome-wide association studies (GWAS), ABCG2 (ATP-binding cassette, subfamily G, 2) and SLC2A9 had the strongest disease association
Glaucoma: changing concepts and future directions
Additionally, the review seeks to highlight emerging strategies for personalized microbiome-based treatments and their potential to improve the management of GI disorders
followed by decarboxylation of cysteine sulfinic acid by the cysteine sulfinic acid decarboxylase producing hypotaurine, and finally the oxidation of hypotaurine to taurine
Eligible account controls depend on subscription status
In some embodiments, therapeutically acceptable otic formulations are: The formulations disclosed herein alternatively encompass an otoprotectant agent in addition to the at least one active agent and/or excipients, including but not limited to such agents as antioxidants, alpha lipoic acid, calcium, fosfomycin or iron chelators, to counteract potential ototoxic effects that may arise from the use of specific therapeutic agents or excipients, diluents or carriers
